← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2005Last known activity
Jan 31, 2026
Timeline
2000s
- Jun 1, 2000
Actinium Pharmaceuticals— Founded
Drugs by trial phase (20 distinct, 10 trials)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT07157514Lead sponsorPhase 2/Phase 3Jan 31, 2026
- NCT07015684CollaboratorPhase 1Apr 28, 2025
- NCT06768905CollaboratorPhase 1/Phase 2Apr 25, 2025
- NCT04512716CollaboratorEarly Phase 1Feb 2, 2021
- NCT03932318Lead sponsorPhase 1/Phase 2Jul 31, 2019
- NCT03867682Lead sponsorPhase 1/Phase 2May 31, 2019
- NCT02998047CollaboratorPhase 1Dec 1, 2016
- NCT02665065Study directorPhase 3Jun 1, 2016
- NCT02665065Lead sponsorPhase 3Jun 1, 2016
- NCT02575963Study directorPhase 1/Phase 2Oct 1, 2012
- NCT02575963Lead sponsorPhase 1/Phase 2Oct 1, 2012
- NCT00672165CollaboratorPhase 1Jul 1, 2005
Details
- Founded
- New York, NY, US Jun 1, 2000
- Last known activity
- Jan 31, 2026